Back to Rathbones Group PLC Rathbones Group PLC

ORMPORMP
11 quarters

Position history for Rathbones Group PLCRathbones Group PLC's holdings in ORAMED PHARMACEUTICALS INC

Rathbones Group PLC holds 233,018 shares of ORMP (ORAMED PHARMACEUTICALS INC), worth $792,261 as of 2026-Q1. ORMP represents 0.0% of Rathbones Group PLC's portfolio.

Current Value

$792,261

Current Shares

233,018

Total Value Change

+$35,875

Total Shares Change

-56,785

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
233,018
0.0%
$792,2610.0%$3.38
0
2025-Q4
Unchanged
233,018
0.0%
$664,1010.0%$2.62
0
2025-Q3
Unchanged
233,018
0.0%
$615,1670.0%$2.52
0
2025-Q2
Decreased
233,018
-1.6%
$524,2900.0%$2.00
0
2025-Q1
Decreased
236,803
-18.3%
$506,7580.0%$2.06
0
2024-Q4
Unchanged
289,803
0.0%
$701,3230.0%$2.17
0
2024-Q3
Unchanged
289,803
0.0%
$707,1190.0%$2.31
0
2024-Q2
Unchanged
289,803
0.0%
$744,7940.0%$2.40
0
2024-Q1
Unchanged
289,803
0.0%
$846,2250.0%$2.72
0
2023-Q4
Unchanged
289,803
0.0%
$669,4450.0%$2.15
0
2023-Q3
New
289,803
-
$756,3860.0%$2.43
34

Other major holders of ORMP: Invesco Ltd., MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used